According to Paratek Pharmaceuticals
's latest financial reports the company has -$0.21 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $-0.18 B | 33.85% |
2021-12-31 | $-0.13 B | 24.96% |
2020-12-31 | $-0.11 B | 157.93% |
2019-12-31 | $-39.65 M | -183.33% |
2018-12-31 | $47.57 M | -42.31% |
2017-12-31 | $82.47 M | 15.21% |
2016-12-31 | $71.59 M | -29.28% |
2015-12-31 | $0.10 B | 6.32% |
2014-12-31 | $95.22 M | 32.73% |
2013-12-31 | $71.74 M | -24.79% |
2012-12-31 | $95.39 M | 45.08% |
2011-12-31 | $65.75 M | 3.04% |
2010-12-31 | $63.81 M | -10.22% |
2009-12-31 | $71.07 M | -15.42% |
2008-12-31 | $84.03 M | 83.68% |
2007-12-31 | $45.74 M | -23.53% |
2006-12-31 | $59.82 M | -198.98% |
2005-12-31 | $-60.45 M | 60.69% |
2004-12-31 | $-37.62 M | |
2002-12-31 | $-6.98 M | 377.86% |
2001-12-31 | $-1.46 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Ultragenyx RARE | $0.27 B | -236.77% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | $26.8 M | -113.31% | ๐บ๐ธ USA |
Agenus
AGEN | -$0.15 B | -26.31% | ๐บ๐ธ USA |